Real-life effectiveness and safety of baricitinib in 17 Japanese patients with alopecia areata: a 60-week single center study

Real-life effectiveness and safety of baricitinib in 17 Japanese patients with alopecia areata: a 60-week single center study

Alopecia areata (AA) is a chronic immune-mediated skin disorder characterized by non-scarring hair loss. Although clinical trials have shown the effectiveness and safety of baricitinib, there are limited reports that have shown real-world evidence of baricitinib in patients with AA. Herein, we prese...

Full description

Saved in:
Bibliographic Details
Main Authors: Akihiko Uchiyama, Takeshi Araki, Keiji Kosaka, Sei-Ichiro Motegi
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Journal of Cutaneous Immunology and Allergy
Subjects:
alopecia areata
baricitinib
real-world data
retrospective study
Japanese
Online Access:https://www.frontierspartnerships.org/articles/10.3389/jcia.2024.13890/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items